Cargando…
Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells
T–lymphokine-activated killer cell–originated protein kinase (TOPK) and maternal embryonic leucine zipper kinase (MELK) have been reported to play critical roles in cancer cell proliferation and maintenance of stemness. In this study, we investigated possible roles of TOPK and MELK in kidney cancer...
Autores principales: | Kato, Taigo, Inoue, Hiroyuki, Imoto, Seiya, Tamada, Yoshinori, Miyamoto, Takashi, Matsuo, Yo, Nakamura, Yusuke, Park, Jae-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951240/ https://www.ncbi.nlm.nih.gov/pubmed/26933922 http://dx.doi.org/10.18632/oncotarget.7755 |
Ejemplares similares
-
TOPK (T‐LAK cell‐originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer
por: Park, Jae‐Hyun, et al.
Publicado: (2017) -
Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer
por: Inoue, Hiroyuki, et al.
Publicado: (2016) -
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
por: Chung, Suyoun, et al.
Publicado: (2012) -
Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2016) -
Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2020)